The national cancer data base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.

Cancer

Volumn 86, Issue 9, 1999, Pages 1877-1882

  Mettlin, Curtis J ^a   Murphy, Gerald P ^b   McDonald, Charles J ^c   Menck, Herman R ^d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NORTHWEST HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

Brachytherapy; Patterns of care; Prostate carcinoma; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

AGE FACTORS; AGED; BRACHYTHERAPY; DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 0033230450     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1877::AID-CNCR32>3.0.CO;2-5     Document Type: Article

References (24)

1. Mettlin C, Murphy GP, Menck H. Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990. Urology 1994;43:488-92.
2. Jones GW, Mettlin C, Murphy GP, Guinan P, Herr HW, Hussey DH, et al. Patterns of care for prostate cancer: results of a national survey of 1984 and 1990. J Am Coll Surg 1995;180:545-54.
3. Mettlin CJ, Murphy GP, Ho R, Menck HR. The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer 1996;77:2162-6.
4. Mettlin C, Murphy GP, Menck HR. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993. Prostate 1997;32:221-6.
5. Mettlin CJ, Murphy GP, Cunningham MP, Menck HR. The National Cancer Data Base report on race, age, and regional variations in prostate cancer treatment. Cancer 1997;80: 1261-6.
6. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. Cancer 1998;93:1679-84.
7. Steele GD Jr., Winchester DP, Menck HR. The National Cancer Data Base: a mechanism for assessment of patient care. Cancer 1993;73:499-504.
8. Menck HR, Cunningham MP, Jessup JM, Eyre HJ, Winchester DP, Scott-Conner CEH, et al. The growth and maturation of the National Cancer Data Base. Cancer 1997;80:2296-304.
9. Flemming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BL, Murphy GP, et al. AJCC cancer staging manual. Philadelphia: J. B. Lippincott, 1997:219-24.
10. Commission on Cancer. Registry operations and data standards (ROADS). Chicago: American College of Surgeons, 1996.
11. Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 1997;13:431-7.
12. Hilaris BS. Brachytherapy in cancer of the prostate: an historical perspective. Semin Surg Oncol 1997;13:399-405.
13. Martel MK, Narayana V. Brachytherapy for the next century: use of image-based treatment planning. Radiat Res 1998; 150:178-88.
14. Arterbery VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A. Quality of life after permanent prostate implant. Semin Surg Oncol 1997;13:461-4.
15. Joly F, Brune D, Couette JE, Lesaunier F, Heron JF, Peny J, et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol 1998;9:751-7.
16. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74.
17. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester JE, Hoak DC, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997;80:442-53.
18. Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998;83:989-1001.
19. Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17:517-22.
20. Zelefsky MJ, Whitmore WF Jr. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 1997;158:23-9.
21. Polascik TJ, Pound CR, DeWeese TL, Walsh PC. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. Urology 1998;51:884-9.
22. Mettlin CJ, Menck HR, Winchester DP, Murphy GP. Comparison of breast, colorectal, lung and prostate cancers reported in the National Cancer Data Base to the Surveillance, Epidemiology and End Results data. Cancer 1997;79:2052-61.
23. Seung SK, Kroll S, Wilder RB, Posner MD, Roach M III. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy. Cancer J Sci Am 1998;4:168-74.
24. Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP, et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999;53:2-10.